Six blood metabolites distinguish metabolic health in obesity
A combined clinical-metabolomic model discriminated healthy from unhealthy obesity with an AUC of 0.78, compared with 0.69 for clinical variables alone.
Frontiers in Endocrinology
In 13,215 adults with obesity from the UK Biobank, researchers evaluated whether circulating metabolites could distinguish metabolically healthy obesity from metabolically unhealthy obesity. Using nuclear magnetic resonance metabolomics, the team identified a six-metabolite signature: HDL_size, S_HDL_CE, XL_HDL_TG, GlycA, M_VLDL_C, and Omega_3.
Adding these six metabolites to age, sex, and waist-to-hip ratio improved discrimination between obesity phenotypes in the test set, raising the area under the curve to 0.78 from 0.69 for clinical variables alone. Among 4,545 participants categorized as metabolically healthy, higher metabolomic risk scores tracked with higher triglycerides, higher HbA1c, lower HDL cholesterol, and more cardiovascular comorbidities. Proteomic profiling in 1,408 participants linked the signature to ten core proteins involved in inflammation, adipokine signaling, and lipid metabolism.
Why it matters
Cardiometabolic decline is a major contributor to age-related disease, yet conventional clinical criteria often fail to capture subclinical dysfunction. Identifying hidden metabolic risk in ostensibly healthy obesity could improve risk stratification and help guide earlier interventions.
Caveats
The findings are based on cross-sectional observational data from the UK Biobank and complete-case analysis. The authors emphasize that the signature requires further validation before it can be applied in clinical settings.
The paper
Third People's Hospital of Chengdu
Frontiers in Endocrinology · 11 Sep 2026 · CC BY